• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory Council

    4/7/26 8:38:00 AM ET
    $VIVO
    Power Generation
    Utilities
    Get the next $VIVO alert in real time by email

    Ms. Mustafa brings a track record from a 23-year tenure at Microsoft, where she headed Global Sales & Partnerships for Industrial Metaverse Core, in the Cloud & AI division of Microsoft

    Based between New York and Abu Dhabi, she was also formerly head of global partnerships for Core 42, which is part of G42, the Abu Dhabi headquartered AI group backed by Mubadala, Microsoft, Silverlake, and the Dalio Family Office

    LONDON, April 07, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Khadija Mustafa to its Advisory Council. Ms. Mustafa brings over two decades of global technology leadership experience, with deep expertise in artificial intelligence strategy, international partnerships, and business commercialization across the United States, the Middle East, Europe, and high-growth emerging markets.

    Khadija Mustafa, Advisory Council Member of VivoPower, said: "I'm pleased to be joining VivoPower. Sovereign AI is becoming the operating system of nations, shaping how they compete, secure their interests, and govern in an increasingly complex geopolitical landscape. The defining question is no longer access to intelligence, but control over the physical foundations that enable it. Leadership in this layer will define the next phase of global competitiveness. VivoPower is building at this critical convergence of energy, land, and compute with clarity and focus, and is uniquely positioned to shape how sovereign AI infrastructure is developed and accessed in the years ahead, an emerging priority for many nations."

    Kevin Chin, Executive Chairman and CEO of VivoPower, said: "I am honored to welcome Khadija to VivoPower. She has built and scaled AI businesses across some of the world's most competitive and strategically important markets, and she understands how infrastructure, capital, and policy intersect in the AI era across multiple sovereign jurisdictions globally. As VivoPower expands its global footprint in powered land and data center infrastructure, her global insights and commercial experience will be a great advantage."

    Ms. Mustafa is the Founder and CEO of Beyyond.ai, a strategic advisory firm helping nations, boards, family offices, funds, and founders build AI ecosystems that align innovative applications with sovereign compute, deep tech, and commercial realities. She is also a Lead Business Mentor and Advisor for the Harvard Alumni Entrepreneurs Accelerator.

    Prior to founding Beyyond.ai, Ms. Mustafa held senior executive roles at the forefront of global AI infrastructure and enterprise technology. She has led international partnership strategies spanning Fortune 500 corporations, high-growth unicorns, and cutting-edge AI startups across multiple continents. Earlier in her career, she spent over two decades at Microsoft, where she headed go-to-market for AI and autonomous systems, played an instrumental role in one of the largest technology acquisitions of its era, valued at $8.5 billion, and oversaw a multi-billion-dollar commercial supply chain for hardware devices, as well as pioneering the expansion of a health technology business across 79 countries in the Middle East and Africa. She also led global partnerships for Core 42, which is part of G42, the Abu Dhabi headquartered AI technology holding company that has global operations and counts Mubadala (a sovereign wealth fund of the United Arab Emirates), Microsoft, Silverlake, and the Dalio Family Office as shareholders.

    Ms. Mustafa's appointment strengthens VivoPower's ability to execute on its global AI infrastructure strategy. Her extensive network across hyperscalers, sovereign institutions, and frontier AI companies — spanning the US, Middle East, Europe, and emerging markets — opens direct pathways to the partnerships and capital flows that matter most in today's AI infrastructure race. Her proven ability to drive large-scale commercial outcomes in complex, fast-moving technology environments will help VivoPower accelerate deal flow, enter new markets, and consolidate its position as a preferred infrastructure partner for the AI era.

    About VivoPower

    Originally founded in 2014 and listed on Nasdaq since 2016, VivoPower is an award-winning B Corporation with a global footprint spanning the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia. Today, VivoPower's mission is to be the independent, trusted partner for sovereign nations that develop and operate sustainable data center infrastructure, ensuring sovereign control over power, data, and national intelligence. In doing so, VivoPower helps sovereign nations bridge the gap between their energy assets and their AI ambitions by providing the Power-to-X infrastructure necessary to build and control their own domestic intelligence hubs.

    Forward-Looking Statements

    This communication includes certain statements that may constitute "forward-looking statements" for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the Company's intention to broaden the Class B conversion program to additional members of the leadership team, the expected impact of the conversion on the Company's capital structure and governance framework, the achievement of performance hurdles, or the benefits of the events or transactions described in this communication. These statements are based on VivoPower's management's current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower's business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, and other factors set forth in VivoPower's filings with the United States Securities and Exchange Commission. Specifically in relation to the conversion to unlisted restricted Class B shares, there is a defined process that needs to be completed for each tranche of shares to be converted, which involves counterparties and regulators, the timing of which is outside the control of the Company. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise.

    Contact 

    Shareholder Enquiries 

    [email protected] 



    Primary Logo

    Get the next $VIVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VIVO

    DatePrice TargetRatingAnalyst
    2/7/2022$28.00 → $30.00Buy
    HC Wainwright & Co.
    11/15/2021$27.00 → $28.00Buy
    HC Wainwright & Co.
    8/9/2021$30.00 → $27.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $VIVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Williams Felicia returned 10,274 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:22:23 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Sazdanoff Catherine returned 16,424 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:21:33 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Rice John Mccune Jr. returned 27,449 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:20:26 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 10, 2021 - Coronavirus (COVID-19) Update: December 10, 2021

    For Immediate Release: December 10, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On December 9, 2021, the FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, inc

    12/10/21 1:56:40 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $VIVO
    SEC Filings

    View All

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $30.00 from $28.00 previously

    2/7/22 6:13:53 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $28.00 from $27.00 previously

    11/15/21 6:32:31 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $27.00 from $30.00 previously

    8/9/21 6:33:26 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 15-12G filed by Meridian Bioscience Inc.

    15-12G - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/13/23 4:31:51 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 10-Q filed by Meridian Bioscience Inc.

    10-Q - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/9/23 8:23:24 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form EFFECT filed by Meridian Bioscience Inc.

    EFFECT - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/6/23 12:15:16 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory Council

    Ms. Mustafa brings a track record from a 23-year tenure at Microsoft, where she headed Global Sales & Partnerships for Industrial Metaverse Core, in the Cloud & AI division of Microsoft Based between New York and Abu Dhabi, she was also formerly head of global partnerships for Core 42, which is part of G42, the Abu Dhabi headquartered AI group backed by Mubadala, Microsoft, Silverlake, and the Dalio Family Office LONDON, April 07, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Khadija Mustafa to

    4/7/26 8:38:00 AM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Receives Nasdaq Approval of Ticker "TEMB" for Planned Tembo Listing at a Targeted Valuation of $838 Million

    Ticker approval marks a key regulatory milestone for the listing of the business combination between VivoPower's subsidiary Tembo e-LV, and Cactus Acquisition Corporation I (CCTS) Tembo has previously announced securing of strategic long term investment capital from the Emirates and hence no structured PIPE capital will be required VivoPower expects to retain a significant equity interest in Tembo following completion of the business combination and separate listing of Tembo LONDON, March 26, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI com

    3/26/26 9:10:00 AM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float

    Follows recently announced share acquisitions totaling 2.65 million shares by board members, including Executive Chairman and CEO, Kevin Chin, who purchased the majority of shares  Conversion program is aligned with VivoPower's broader capital strategy to minimize dilution following the recent cancellation of the Company's ATM and F-3 registration statement Strategic intent is to further align with shareholder interest, given that unlisted restricted Class B shares are non-tradeable with enhanced voting rights LONDON, March 20, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data cent

    3/20/26 9:32:13 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Financials

    Live finance-specific insights

    View All

    Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

    Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners LLC ("SJL") (collectively, the "Consortium") announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an a

    7/7/22 7:17:00 AM ET
    $VIVO
    Power Generation
    Utilities

    MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

    CINCINNATI, May 6, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced financial results for the second quarter ended March 31, 2022. Second Quarter Fiscal 2022 Highlights (Comparison to Second Quarter Fiscal 2021): Consolidated net revenues totaled $111.2 million, the highest in Company history, with both segments ahead of expectationsLife Science segment delivered record net revenues of $70.1 millionDiagnostics segment net revenues increased 29% year-over-year to a record $41.1 millionLaunched Lyo-Ready™ sample specific master mixes for bloodResumed

    5/6/22 8:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

    CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc.  The transaction closed on April 30, 2022. EUPROTEIN Inc. offers custom development and production of high-quality bioresearch reagents, with a particular focus on human and other mammalian proteins and recombinant monoclonal antibodies.  This acquisition will help

    5/2/22 8:47:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/9/23 11:27:43 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13D/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13D/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/3/23 2:06:19 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    1/31/23 11:06:04 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Leadership Updates

    Live Leadership Updates

    View All

    VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory Council

    Ms. Mustafa brings a track record from a 23-year tenure at Microsoft, where she headed Global Sales & Partnerships for Industrial Metaverse Core, in the Cloud & AI division of Microsoft Based between New York and Abu Dhabi, she was also formerly head of global partnerships for Core 42, which is part of G42, the Abu Dhabi headquartered AI group backed by Mubadala, Microsoft, Silverlake, and the Dalio Family Office LONDON, April 07, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Khadija Mustafa to

    4/7/26 8:38:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Bioscience Announces Retirement of CFO Bryan Baldasare

    CINCINNATI, Dec. 2, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021.  The Company is engaging an executive search firm in the recruitment of a new chief financial officer.  The Company appointed Julie Smith to the position of Senior Vice President, Controller, effective December 6, 2021, and principal accounting officer, effective January 1, 2022.

    12/2/21 8:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Bioscience Announces Retirement of Chairman David Phillips

    CINCINNATI, Nov. 24, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022.  The Board of Directors will elect a new chair when Mr. Phillips' term expires and will not replace the vacated seat, which will reduce the number of directors to eight. Mr. Phillips joined the Meridian Board of Directors in 2000 and ha

    11/24/21 9:05:00 AM ET
    $VIVO
    Power Generation
    Utilities